Paper3127076
Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
Horowitz JD and 6 others. Circulation, 1988. Cited by 94 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Papers, record 3127076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3127076
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylcysteine | Major topic |
| Angina Pectoris | Major topic |
| Angina, Unstable | Major topic |
| Nitroglycerin | Major topic |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Hypotension | |
| Male | |
| Myocardial Infarction | |
| Random Allocation | |
| Risk Factors |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38136193 | N-Acetylcysteine and Atherosclerosis: Promises and Challenges. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38136193 | PubMed |
| 37005695 | Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania. | Pilot Feasibility Stud | 2023 | https://conductscience.org/library/papers/37005695 | PubMed |
| 34727343 | Oral N-acetylcysteine as an adjunct to standard medical therapy improved heart function in cases with stable class II and III systolic heart failure. | Ir J Med Sci | 2022 | https://conductscience.org/library/papers/34727343 | PubMed |
| 34208683 | N-Acetylcysteine (NAC): Impacts on Human Health. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34208683 | PubMed |
| 33048324 | Progression of heart failure is attenuated by antioxidant therapy with N-acetylcysteine in myocardial infarcted female rats. | Mol Biol Rep | 2020 | https://conductscience.org/library/papers/33048324 | PubMed |
| 31857574 | Mitochondrial dysfunction and oxidative stress in heart disease. | Exp Mol Med | 2019 | https://conductscience.org/library/papers/31857574 | PubMed |
| 23436032 | Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants. | Heart Fail Rev | 2014 | https://conductscience.org/library/papers/23436032 | PubMed |
| 16440146 | Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction. | Heart Vessels | 2006 | https://conductscience.org/library/papers/16440146 | PubMed |
| 16187967 | Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance. | Br J Clin Pharmacol | 2005 | https://conductscience.org/library/papers/16187967 | PubMed |
| 12652159 | Nitric oxide, platelet function, myocardial infarction and reperfusion therapies. | Heart Fail Rev | 2003 | https://conductscience.org/library/papers/12652159 | PubMed |
| 11444642 | N-acetylcysteine improves microcirculatory flow during smoking: new effects of an old drug with possible benefits for smokers. | Clin Cardiol | 2001 | https://conductscience.org/library/papers/11444642 | PubMed |
| 10651168 | Effects of N-acetylcysteine on nitroglycerin-induced relaxation and protein phosphorylation of porcine coronary arteries. | Heart Vessels | 1998 | https://conductscience.org/library/papers/10651168 | PubMed |
| 7947366 | Mechanisms of nitrate tolerance. | Cardiovasc Drugs Ther | 1994 | https://conductscience.org/library/papers/7947366 | PubMed |
| 7873468 | Nitrates for unstable angina. | Cardiovasc Drugs Ther | 1994 | https://conductscience.org/library/papers/7873468 | PubMed |
| 7729327 | Nitrate tolerance in angina therapy. How to avoid it. | Drugs | 1995 | https://conductscience.org/library/papers/7729327 | PubMed |
| 7531993 | Inhibition of platelet aggregation by transdermal glyceryl trinitrate. | Br Heart J | 1994 | https://conductscience.org/library/papers/7531993 | PubMed |
| 2661197 | Nitrate tolerance. A review of the evidence. | Drugs | 1989 | https://conductscience.org/library/papers/2661197 | PubMed |
| 2598989 | The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2598989 | PubMed |
| 2511992 | S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators. | Br J Pharmacol | 1989 | https://conductscience.org/library/papers/2511992 | PubMed |
| 2503018 | Glyceryl trinitrate and platelet aggregation: effects of N-acetyl-cysteine. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2503018 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3127076
GET https://conductscience.org/api/papers/v1/3127076/cited_by?page=2